Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362318 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) (pSer573) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around phosphorylation site of pSer573 (L-L-S (p) -P-G) derived from Human RelB. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- pSer573
- Isotype
- IgG
- Vial size
- 100 μL
- Concentration
- 1 mg/mL
- Storage
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Submitted references The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces.
Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control.
Pyz E, Naidenko O, Miyake S, Yamamura T, Berberich I, Cardell S, Kronenberg M, Herrmann T
Journal of immunology (Baltimore, Md. : 1950) 2006 Jun 15;176(12):7447-55
Journal of immunology (Baltimore, Md. : 1950) 2006 Jun 15;176(12):7447-55
The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces.
Kaetzel CS
Immunological reviews 2005 Aug;206:83-99
Immunological reviews 2005 Aug;206:83-99
Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control.
Marienfeld R, Berberich-Siebelt F, Berberich I, Denk A, Serfling E, Neumann M
Oncogene 2001 Dec 6;20(56):8142-7
Oncogene 2001 Dec 6;20(56):8142-7
No comments: Submit comment
No validations: Submit validation data